PHARMACOKINETIC STUDIES WITH CHLORTHALIDONE (HYGROTON) IN MAN

被引：54

作者：

RIESS, W ^{[1
]}

DUBACH, UC ^{[1
]}

BURCKHARDT, D ^{[1
]}

THEOBALD, W ^{[1
]}

VUILLARD, P ^{[1
]}

ZIMMERLI, M ^{[1
]}

机构：

[1] UNIV BASEL,KANTONSSPITAL,MED POLIKLIN,DEPT INNERE MED,CH-4051 BASEL,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 12卷 / 05期

关键词：

D O I：

10.1007/BF00562454

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：375 / 382

页数：8

共 8 条

[1]

BUENGER P, 1961, ARZNEIMITTELFORSCH, V11, P247

[2] BINDING OF CHLORTHALIDONE (HYGROTONR) TO BLOOD COMPONENTS IN MAN [J].

DIETERLE, W ;

WAGNER, J ;

FAIGLE, JW .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (01) :37-42

[3]

DOST FH, 1968, GRUNDLAGEN PHARMAKOK, P278

[4] APPLICATION OF EXTRACTIVE ALKYLATION TECHNIQUE TO GAS-CHROMATOGRAPHIC DETERMINATION OF CHLORTHALIDONE IN PLASMA IN NANOGRAM QUANTITIES [J].

ERVIK, M ;

GUSTAVII, K .

ANALYTICAL CHEMISTRY, 1974, 46 (01) :39-42

[5] ZUR KONSTITUTION VON BENZOPHENON-2-CARBONSAURE-DERIVATEN [J].

GRAF, W ;

GIROD, E ;

SCHMID, E ;

STOLL, WG .

HELVETICA CHIMICA ACTA, 1959, 42 (03) :1085-1101

[6]

STENGER E G, 1959, Schweiz Med Wochenschr, V89, P1126

[7] PHARMACOKINETICS .2. KIDNEY AND URINARY EXCRETION [J].

WAGNER, JG .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1968, 2 (04) :95-&

[8] PER CENT ABSORBED TIME PLOTS DERIVED FROM BLOOD LEVEL AND/OR URINARY EXCRETION DATA [J].

WAGNER, JG ;

NELSON, E .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (06) :610-&

← 1 →